CTCBIO Inc Cash Flow Reinvestment Rate
CTCBIO Inc cash flow reinvestment rate. CTCBIO Inc (060590) has a Cash Flow Reinvestment Rate of 0.04x as of September 2025, reinvesting ₩212.02 Million (capex ₩212.02 Million ) from operating cash flow of ₩5.64 Billion. Explore cash flow to debt ratio of CTCBIO Inc to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of CTCBIO Inc (2013–2024)
Cash flow reinvestment rate of CTCBIO Inc from 2013 to 2024. Historical reinvestment intensity for CTCBIO Inc across 10 annual periods. Explore 060590 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
CTCBIO Inc Cash Flow Reinvestment Rate by Year (2013–2024)
CTCBIO Inc cash flow reinvestment rate by year from 2013 to 2024. Year-by-year capital reinvestment analysis for CTCBIO Inc. For the full cash flow conversion analysis, see cash flow conversion of CTCBIO Inc.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.19x | ₩5.36 Billion | ₩4.50 Billion | ₩2.14 Billion | ▲ +176.9% |
| 2023 | 0.43x | ₩3.54 Billion | ₩8.22 Billion | ₩1.88 Billion | ▲ +111.7% |
| 2022 | 0.20x | ₩3.71 Billion | ₩18.22 Billion | ₩3.17 Billion | ▼ -83.4% |
| 2021 | 1.22x | ₩7.89 Billion | ₩6.46 Billion | ₩1.67 Billion | ▼ -80.3% |
| 2020 | 6.22x | ₩3.17 Billion | ₩510.09 Million | ₩1.92 Billion | ▼ -39.6% |
| 2019 | 10.30x | ₩17.25 Billion | ₩1.68 Billion | ₩2.22 Billion | ▼ -25.8% |
| 2017 | 13.87x | ₩4.10 Billion | ₩295.30 Million | ₩3.90 Billion | ▲ +425.2% |
| 2016 | 2.64x | ₩18.12 Billion | ₩6.86 Billion | ₩13.46 Billion | ▼ -85.6% |
| 2015 | 18.35x | ₩26.37 Billion | ₩1.44 Billion | ₩23.71 Billion | ▲ +731.6% |
| 2013 | 2.21x | ₩6.05 Billion | ₩2.74 Billion | ₩6.05 Billion | — |